| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 11.488 | 11.882 | 15.821 | 14.654 | 12.150 | 7.668 | 9.605 | 10.030 | 10.044 | 12.395 |
| Total Income - EUR | 11.488 | 11.882 | 15.821 | 14.654 | 12.150 | 7.668 | 9.605 | 10.030 | 10.044 | 12.395 |
| Total Expenses - EUR | 9.029 | 7.028 | 6.114 | 7.140 | 6.427 | 4.619 | 6.887 | 11.208 | 12.928 | 17.479 |
| Gross Profit/Loss - EUR | 2.460 | 4.855 | 9.707 | 7.514 | 5.722 | 3.049 | 2.718 | -1.178 | -2.884 | -5.084 |
| Net Profit/Loss - EUR | 2.115 | 4.498 | 9.232 | 7.074 | 5.356 | 2.884 | 2.620 | -1.372 | -2.984 | -5.084 |
| Employees | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Mededen S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 2.527 | 500 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 10.215 |
| Current Assets | 1.646 | 4.481 | 9.596 | 7.262 | 5.505 | 3.062 | 5.727 | 154 | 13 | 3.250 |
| Inventories | 43 | 106 | 0 | 0 | 0 | 19 | 20 | 117 | 0 | 0 |
| Receivables | 28 | 2.004 | 3.065 | 258 | 0 | 0 | 0 | 0 | 0 | 63 |
| Cash | 1.575 | 2.371 | 6.532 | 7.004 | 5.505 | 3.043 | 5.706 | 37 | 13 | 3.187 |
| Shareholders Funds | 3.998 | 4.543 | 9.276 | 7.154 | 5.406 | 2.933 | 5.488 | -1.324 | -4.303 | -9.363 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 176 | 439 | 320 | 108 | 99 | 129 | 238 | 1.477 | 4.317 | 22.828 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "9623 - 9623" | |||||||||
| CAEN Financial Year |
4932
|
|||||||||
Comments - Mededen S.r.l.